Current management of congestive heart failure in infants and children.
Although the general goals of therapy for the medical and nursing management of CHF in children have not changed in the last decade, advances have been made in understanding the unique characteristics of the neonatal heart and tailoring therapy to best support cardiac function (Table 6). In addition, strides have been made in manipulating the loading conditions of the ventricle to enhance cardiac output, which has fostered the development of new therapeutic agents and more aggressive treatment of these patients with improved outcomes. In situations in which the infant is unresponsive to therapy, surgical intervention is now done at an earlier age with good results. When surgery is not an option and the patient continues to deteriorate despite maximum medical management, mechanical support can be instituted as a bridge to transplantation.
Kohr
L M
LM
Cardiovascular Program, Children's Hospital, Boston, Massachusetts, USA.
O'Brien
P
P
D002316:Cardiotonic Agents / Q000627:therapeutic use; D002648:Child; D004232:Diuretics / Q000627:therapeutic use; D006333:Heart Failure / Q000175:diagnosis / Q000188:drug therapy* / Q000451:nursing / Q000503:physiopathology; D006801:Humans; D007223:Infant; D010290:Parents / Q000193:education; D010347:Patient Care Planning; D014665:Vasodilator Agents / Q000627:therapeutic use
D002316:Cardiotonic Agents; D004232:Diuretics; D014665:Vasodilator Agents